Day: December 2, 2020

TORONTO, Dec. 02, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies...

On December 2, 2020 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar members of the management board Zane Kotāne un Elena Bushberg informed about the recent performance of the company, sales activities in Russia and financial results of third quarter of 2020 and 9 months of 2020.The recorded webinar is available online: https://bit.ly/3ly1Aaf, and the presentation, demonstrated during the webinar, is available in the attachment. Methodology for alternative performance indicators is disclosed in Annual report for 2019 (page 21)Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!JSC “Olainfarm” is one of the largest companies in the Baltic States with more than 45 years of experience in the production...

Š.g. 2. decembrī AS „Olainfarm” aizvadīja virtuālo konferenci investoriem. Konferences laikā AS „Olainfarm” valdes locekles Zane Kotāne un Elena Bushberg informēja par uzņēmuma aktualitātēm un pārdošanas aktivitātēm Krievijā, kā arī analizēja 2020. gada 3. ceturkšņa un 2020. gada 9 mēnešu finanšu rezultātus.Virtuālās konferences ieraksts ir pieejams šeit: https://bit.ly/3ly1Aaf.Savukārt, virtuālās konferences laikā demonstrētā prezentācija ir pievienota paziņojuma pielikumā. Alternatīvo snieguma rādītāju aprēķina metodika ir atklāta 2019.gada pārskatā (21.lpp.).Olainfarm pateicas visiem, kas piedalījās vebinārā un aicina sekot līdz informācijai par nākamo virtuālo konferenci!AS “Olainfarm” ir viens no lielākajiem uzņēmumiem Baltijas valstīs ar vairāk nekā 45 gadu pieredzi zāļu un ķīmisko farmaceitisko produktu ražošanā. AS “Olainfarm”...

To Nasdaq OMX Copenhagen A/SPublic announcement no. 484December 2nd, 2020RELATED PARTY TRANSACTIONGlunz & Jensen Holding A/S announces that the company today has received pursuant to section 38 of the Capital Market Act and section 55 of the Danish Companies Act, where Heliograph Holding GmbH (“Heliograph”) notifies Glunz & Jensen Holding A/S (“Glunz & Jensen “) that Heliograph today has increased their shareholding in Glunz & Jensen by purchasing 125 shares in Glunz & Jensen at nominal DKK 20.See attached information for further details.For further information please contact:CEO Martin Overgaard Hansen: phone +45 22 60 84 05Chairman of the board Flemming Nyenstad Enevoldsen: phone +45 40 43 13 03AttachmentHG FT 02 12 2020

See notice in the attachment. Attachment20201202_-_Skeljungur_-_Strengur_hf._-_Flöggun

Sjá flöggunartilkynningu í viðhengi.Viðhengi20201202_-_Skeljungur_-_Strengur_hf._-_Flöggun

NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) — AB International Group Corp. (OTCQB: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced that on November 23, 2020, it entered into a Termination and Release Agreement with Armada Capital Partners LLC (“Armada”), a Delaware limited liability company. Pursuant to the agreement, the parties agreed to terminate the warrant issued in favor of Armada to purchase 4,200 shares of our common stock for a payment of $20,000. The parties also entered into a mutual release of claims. On November 30, 2020, it entered into a Termination and Release Agreement with Crown Bridge Partners, LLC, (“Crown”), a New York limited liability company. Pursuant to the agreement, the parties agreed to terminate the warrants, dated January 8, 2020 and July 23, 2020, issued in...

OSLO, Norway, Dec. 02, 2020 (GLOBE NEWSWIRE) — Opera GX [NASDAQ: OPRA] is introducing Razer Chroma RGB Lighting Effects that allow Chroma-enabled devices to respond to your browsing with custom Chroma RGB Lighting Effects.“Let’s face it: you need to be focused in a game and GX is the perfect place to have fun with your setup and make it shine,” said Maciej Kocemba, Head of Opera GX.Opera GX is the world’s first browser designed for gamers. GX initially launched with Razer Chroma RGB integration that allowed Razer Gear to match the colors of the browser. Opera is now stepping it up with dynamic Chroma Lighting Effects that light up gamers’ Razer gear with custom animations whenever they start the browser, open new tabs, get a notification, activate the RAM, CPU and network limiters or finish a file download.“We’re glad to see Opera...